Avoiding Antitrust Issues - - BioPharm International

ADVERTISEMENT

Avoiding Antitrust Issues


BioPharm International
Volume 1, Issue 8

35. FTC Docket No. C-3945. In the Matter of Abbott Laboratories and Geneva Pharmaceuticals, Inc. Complaint. 2000, May 26. Available at: http:// http://www.ftc.gov/os/2000/05/c3945complaint.htm.

36. FTC Docket No. 9293. In the Matter of Hoechst Marion Roussel, Inc, Carderm Capital LP, and Andrx Corp. Consent Order and FTC Commission Actions. 2001, May 8, 11. Available at: http:// http://www.ftc.gov/os/2001/05/hoechstdo.htm and http:// http://www.ftc.gov/opa/2001/05/fyi0130.htm.

37. FTC Docket No. 9297. In the Matter of Schering-Plough Corp, Upsher-Smith Laboratories, and American Home Products Corp. 2001 November 20. Available at: http:// http://www.ftc.gov/os/adjpro/d9297/011109stip.pdf

38. Schering-Plough Corp v FTC, 402 F3d (11th Cir 2005 March 8).

39. In Re Cardizem CD Antitrust Litigation, 332 F3d 896 (6th Cir 2003).

40. In re Terazosin Hydrochloride Antitrust Litigation, 164 F Supp 2d 1340 (SD Fla 2000).

41. Valley Drug Co. v Geneva Pharmaceuticals, Inc, 344 F3d 1294 (11th Cir 2003).

42. Jefferson Parish Hospital Dist No. 2 v Hyde, 466 US 2 (1984).

43. Sandoz Pharmaceuticals Corp, 115 FTC 625 (1992) (consent order). Summarized at: http:// http://www.ftc.gov/bc/rxupdate021108.htm.

44. Horton TJ. Protecting Your Life Sciences and Biotech Licenses from the Specter of the Antitrust Laws. Licensing J. 2005 March:1.

45. Carson P, Jackson M, Mandrgoc M. Maximizing prosperity through strategic licensing. Paper presented at: American Conference Institute Conference on Pharma and Biotech In-Licensing Co-Development and Co-Promotion Agreements; 2002 October 21; New York, NY.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Novartis Sells Influenza Vaccine Business to CSL for $275 Million
October 27, 2014
Author Guidelines
Source: BioPharm International,
Click here